ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Lyra Therapeutics Inc

Lyra Therapeutics Inc (LYRA)

0,175
0,0084
(5,04%)
Geschlossen 23 März 9:00PM
0,173246
-0,00175
(-1,00%)
Nach Börsenschluss: 12:59AM
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,173246
Gebot
0,1681
Fragen
0,24
Volumen
848.226
0,155 Tagesbereich 0,1766
0,144 52-Wochen-Bereich 6,79
Marktkapitalisierung
Handelsende
0,1666
Handelsbeginn
0,1618
Letzte Trade
56
@
0.1789
Letzter Handelszeitpunkt
Finanzvolumen
US$ 139.479
VWAP
0,164436
Durchschnittliches Volumen (3 Mio.)
1.194.141
Ausgegebene Aktien
65.880.561
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,18
Gewinn pro Aktie (EPS)
-0,95
Erlöse
1,56M
Nettogewinn
-62,68M

Über Lyra Therapeutics Inc

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Lyra Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LYRA. The last closing price for Lyra Therapeutics was US$0,17. Over the last year, Lyra Therapeutics shares have traded in a share price range of US$ 0,144 to US$ 6,79.

Lyra Therapeutics currently has 65.880.561 shares in issue. The market capitalisation of Lyra Therapeutics is US$10,98 million. Lyra Therapeutics has a price to earnings ratio (PE ratio) of -0.18.

LYRA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0027461.610557184750.17050.18390.14411462220.16514145CS
4-0.030754-15.07549019610.2040.22180.1449673680.18611195CS
12-0.008054-4.442360728080.18130.2450.14411941410.19709211CS
26-0.103654-37.43373058870.27690.29980.14414456480.20799737CS
52-5.906754-97.15055921056.086.790.14418715450.49647758CS
156-4.276754-96.10683146074.458.180.1447284671.09972427CS
260-20.826754-99.175019047621220.1444818081.82723781CS

LYRA - Frequently Asked Questions (FAQ)

What is the current Lyra Therapeutics share price?
The current share price of Lyra Therapeutics is US$ 0,173246
How many Lyra Therapeutics shares are in issue?
Lyra Therapeutics has 65.880.561 shares in issue
What is the market cap of Lyra Therapeutics?
The market capitalisation of Lyra Therapeutics is USD 10,98M
What is the 1 year trading range for Lyra Therapeutics share price?
Lyra Therapeutics has traded in the range of US$ 0,144 to US$ 6,79 during the past year
What is the PE ratio of Lyra Therapeutics?
The price to earnings ratio of Lyra Therapeutics is -0,18
What is the cash to sales ratio of Lyra Therapeutics?
The cash to sales ratio of Lyra Therapeutics is 7,2
What is the reporting currency for Lyra Therapeutics?
Lyra Therapeutics reports financial results in USD
What is the latest annual turnover for Lyra Therapeutics?
The latest annual turnover of Lyra Therapeutics is USD 1,56M
What is the latest annual profit for Lyra Therapeutics?
The latest annual profit of Lyra Therapeutics is USD -62,68M
What is the registered address of Lyra Therapeutics?
The registered address for Lyra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Lyra Therapeutics website address?
The website address for Lyra Therapeutics is lyratherapeutics.com
Which industry sector does Lyra Therapeutics operate in?
Lyra Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
264,42M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
175,77M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,98M

LYRA Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen